The full text of "Expert Consensus on Resection of Chest Wall Tumors and Chest Wall Reconstruction (2021 Edition)" was published in Translational Lung Cancer Research in November 2021. The corresponding author is Jiang Tao, Li Xiaofei, and Huang Lijun. Here is a brief introduction to the main content:
-
Extended resection is recommended for desmoid fibromatosis of the chest wall (category 1 recommendation).
-
After excluding distant metastases by a multidisciplinary team, solitary plasmacytoma of the chest wall can be treated by wide - range resection and adjuvant radiotherapy (category 3 recommendation).
Unless the tumor involves important organs or structures (including large blood vessels, heart, trachea, joints, and spine), an attempt should be made to achieve an R0 resection with a tumor - free margin of more than 2 cm.
For patients who have undergone unplanned resection of chest wall tumors for the first time, salvage extended resection should be carried out as soon as possible within 1 - 3 months after the previous operation.
The current TNM staging criteria for bone tumors and soft tissue sarcomas (American Joint Committee on Cancer) are not applicable to chest wall sarcomas.
When the maximum diameter of the chest wall defect in adults and adolescents exceeds 5 cm, rigid implants are required for chest wall reconstruction.
For non - small - cell lung cancer invading the chest wall, extended resection combined with neoadjuvant and/or adjuvant therapy is recommended for patients with stage T3 - 4N0 - 1M0.
Since there is a lack of clear guidelines, these consensus on controversial issues regarding chest wall tumors may serve as important guidance for clinical practice in the coming years.